XML 19 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 139,646 $ 111,202
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 62,833 52,525
Equity method earnings (456) (655)
Gain on step acquisitions (13,644) 0
Loss on extinguishment of debt 7,220 0
Foreign currency losses 14,960 (2,381)
Stock-based compensation 20,311 14,493
Deferred taxes (658) 6,711
Changes in operating assets and liabilities:    
Accounts receivable (14,345) (5,115)
Inventories, net (26,865) 5,039
Prepaid expenses and other (28,387) (16,455)
Other assets (2,150) (3,960)
Accounts payable (3,821) (906)
Accrued expenses (33,178) (9,701)
Other liabilities (7,616) 5,009
Net cash provided by operating activities 113,850 155,806
Cash flows from investing activities:    
Purchases of property and equipment (42,293) (38,965)
Proceeds on investment sales 11,536 11,269
Purchases of investments (11,420) (8,244)
Acquisitions (net of cash acquired) (28,311) 0
Investment in equity investee (4,750) (31,745)
Net cash used in investing activities (75,238) (67,685)
Cash flows from financing activities:    
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards 8,993 16,377
Payments on long-term debt (534,341) (72,260)
Payment of cash dividends (60,395) (57,065)
Payment of debt issuance costs (7,243) 0
Proceeds from debt 582,398 67,000
Repurchases of shares of common stock (48,222) (47,835)
Net cash used in financing activities (58,810) (93,783)
Effect of exchange rate changes on cash (16,135) 12,185
Net increase (decrease) in cash and cash equivalents (36,333) 6,523
Cash and cash equivalents, beginning of period 426,399 357,246
Cash and cash equivalents, end of period $ 390,066 $ 363,769